Biblio

Export 1068 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
C. Trieu, Van Harten, A. C., Leeuwis, A. E., Exalto, L. G., Hooghiemstra, A. M., Verberk, I. M. W., Allaart, C. P., La Rocca, H. - P. Brunner-, L Kappelle, J., van Oostenbrugge, R. J., Biessels, G. - J., Teunissen, C. E., and van der Flier, W. M., Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis., J Alzheimers Dis, 2024.
C. Milano, Hoxhaj, D., Del Chicca, M., Pascazio, A., Paoli, D., Tommasini, L., Vergallo, A., Pizzanelli, C., Tognoni, G., Nuti, A., Ceravolo, R., Siciliano, G., Hampel, H., and Baldacci, F., Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers., J Alzheimers Dis, vol. 94, no. 2, pp. 611-625, 2023.
C. Milano, Hoxhaj, D., Del Chicca, M., Pascazio, A., Paoli, D., Tommasini, L., Vergallo, A., Pizzanelli, C., Tognoni, G., Nuti, A., Ceravolo, R., Siciliano, G., Hampel, H., and Baldacci, F., Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers., J Alzheimers Dis, vol. 94, no. 2, pp. 611-625, 2023.
S. Thibeau, G McFall, P., Camicioli, R., and Dixon, R. A., Alzheimer's Disease Biomarkers Interactively Influence Physical Activity, Mobility, and Cognition Associations in a Non-Demented Aging Population., J Alzheimers Dis, vol. 60, no. 1, pp. 69-86, 2017.
M. Levy Nogueira, Samri, D., Epelbaum, S., Lista, S., Suppa, P., Spies, L., Hampel, H., Dubois, B., and Teichmann, M., Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case Reports., J Alzheimers Dis, vol. 60, no. 2, pp. 577-583, 2017.
A. Xu, Kouznetsova, V. L., and Tsigelny, I. F., Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning., J Alzheimers Dis, vol. 86, no. 2, pp. 841-859, 2022.
A. Watad, Bragazzi, N. L., Tiosano, S., Yavne, Y., Comaneshter, D., Cohen, A. D., and Amital, H., Alzheimer's Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study., J Alzheimers Dis, vol. 65, no. 1, pp. 117-124, 2018.
R. C. Petersen, Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., and Weiner, M. W., Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization., Neurology, vol. 74, no. 3, pp. 201-9, 2010.
R. C. Petersen, Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., and Weiner, M. W., Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization., Neurology, vol. 74, no. 3, pp. 201-9, 2010.
Q. - X. Li, Villemagne, V. L., Doecke, J. D., Rembach, A., Sarros, S., Varghese, S., McGlade, A., Laughton, K. M., Pertile, K. K., Fowler, C. J., Rumble, R. L., Trounson, B. O., Taddei, K., Rainey-Smith, S. R., Laws, S. M., Robertson, J. S., Evered, L. A., Silbert, B., Ellis, K. A., Rowe, C. C., S Macaulay, L., Darby, D., Martins, R. N., Ames, D., Masters, C. L., and Collins, S., Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study., J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
Q. - X. Li, Villemagne, V. L., Doecke, J. D., Rembach, A., Sarros, S., Varghese, S., McGlade, A., Laughton, K. M., Pertile, K. K., Fowler, C. J., Rumble, R. L., Trounson, B. O., Taddei, K., Rainey-Smith, S. R., Laws, S. M., Robertson, J. S., Evered, L. A., Silbert, B., Ellis, K. A., Rowe, C. C., S Macaulay, L., Darby, D., Martins, R. N., Ames, D., Masters, C. L., and Collins, S., Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study., J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
A. Griciuc, Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. Hoon, Hyman, B. T., and Tanzi, R. E., Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta., Neuron, vol. 78, no. 4, pp. 631-43, 2013.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood., J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
C. Babiloni, Noce, G., Di Bonaventura, C., Lizio, R., Eldellaa, A., Tucci, F., Salamone, E. M., Ferri, R., Soricelli, A., Nobili, F., Famá, F., Arnaldi, D., Palma, E., Cifelli, P., Marizzoni, M., Stocchi, F., Bruno, G., Di Gennaro, G., Frisoni, G. B., and Del Percio, C., Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment., J Alzheimers Dis, vol. 88, no. 3, pp. 903-931, 2022.
M. Edsbagge, Andreasson, U., Ambarki, K., Wikkelsø, C., Eklund, A., Blennow, K., Zetterberg, H., and Tullberg, M., Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate., J Alzheimers Dis, vol. 58, no. 3, pp. 821-828, 2017.
C. - H. Yun, Lee, H. - Y., Lee, S. Ku, Kim, H., Seo, H. Suk, Bang, S. Ae, Kim, S. Eun, Greve, D. N., Au, R., Shin, C., and Thomas, R. J., Amyloid Burden in Obstructive Sleep Apnea., J Alzheimers Dis, vol. 59, no. 1, pp. 21-29, 2017.
I. Gureviciene, Gurevicius, K., Mugantseva, E., Kislin, M., Khiroug, L., and Tanila, H., Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-β., J Alzheimers Dis, vol. 55, no. 1, pp. 147-157, 2017.
A. Tiiman, Jelic, V., Jarvet, J., Järemo, P., Bogdanovic, N., Rigler, R., Terenius, L., Gräslund, A., and Vukojević, V., Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis., J Alzheimers Dis, vol. 68, no. 2, pp. 571-582, 2019.
A. Tiiman, Jelic, V., Jarvet, J., Järemo, P., Bogdanovic, N., Rigler, R., Terenius, L., Gräslund, A., and Vukojević, V., Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis., J Alzheimers Dis, vol. 68, no. 2, pp. 571-582, 2019.
S. - K. Herukka, Rummukainen, J., Ihalainen, J., Fraunberg, Mvon Und Zu, Koivisto, A. M., Nerg, O., Puli, L. K., Seppälä, T. T., Zetterberg, H., Pyykkö, O. T., Helisalmi, S., Tanila, H., Alafuzoff, I., Hiltunen, M., Rinne, J., Soininen, H., Jääskeläinen, J. E., and Leinonen, V., Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus., J Alzheimers Dis, 2015.
M. Abdullah, Takase, H., Nunome, M., Enomoto, H., Ito, J. - I., Gong, J. - S., and Michikawa, M., Amyloid-β Reduces Exosome Release from Astrocytes by Enhancing JNK Phosphorylation., J Alzheimers Dis, vol. 53, no. 4, pp. 1433-41, 2016.
M. Narukawa, Takahashi, S., Saito, T., Saido, T. C., and Misaka, T., Analysis of Taste Sensitivities in App Knock-In Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 76, no. 3, pp. 997-1004, 2020.
J. Denner, Tanzi, R., and Jacobson, S., Animal Models of Alzheimer's Disease Should Be Controlled for Roseolovirus., J Alzheimers Dis, vol. 77, no. 2, pp. 543-545, 2020.
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies., Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
E. C. K. Tan, Eriksdotter, M., Garcia-Ptacek, S., Fastbom, J., and Johnell, K., Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia., J Alzheimers Dis, vol. 65, no. 2, pp. 589-596, 2018.

Pages